Logo image
Wnt/β-Catenin Signaling Determines the Vasculogenic Fate of Postnatal Mesenchymal Stem Cells
Journal article   Open access

Wnt/β-Catenin Signaling Determines the Vasculogenic Fate of Postnatal Mesenchymal Stem Cells

Zhaocheng Zhang, Felipe Nör, Min Oh, Carolina Cucco, Songtao Shi and Jacques E Nör
Stem cells (Dayton, Ohio), Vol.34(6), pp.1576-1587
06/2016
DOI: 10.1002/stem.2334
PMCID: PMC5338744
PMID: 26866635
url
https://doi.org/10.1002/stem.2334View
Published (Version of record) Open Access

Abstract

Vasculogenesis is the process of de novo blood vessel formation observed primarily during embryonic development. Emerging evidence suggest that postnatal mesenchymal stem cells are capable of recapitulating vasculogenesis when these cells are engaged in tissue regeneration. However, the mechanisms underlining the vasculogenic differentiation of mesenchymal stem cells remain unclear. Here, we used stem cells from human permanent teeth (dental pulp stem cells [DPSC]) or deciduous teeth (stem cells from human exfoliated deciduous teeth [SHED]) as models of postnatal primary human mesenchymal stem cells to understand mechanisms regulating their vasculogenic fate. GFP-tagged mesenchymal stem cells seeded in human tooth slice/scaffolds and transplanted into immunodeficient mice differentiate into human blood vessels that anastomize with the mouse vasculature. In vitro, vascular endothelial growth factor (VEGF) induced the vasculogenic differentiation of DPSC and SHED via potent activation of Wnt/β-catenin signaling. Further, activation of Wnt signaling is sufficient to induce the vasculogenic differentiation of postnatal mesenchymal stem cells, while Wnt inhibition blocked this process. Notably, β-catenin-silenced DPSC no longer differentiate into endothelial cells in vitro, and showed impaired vasculogenesis in vivo. Collectively, these data demonstrate that VEGF signaling through the canonical Wnt/β-catenin pathway defines the vasculogenic fate of postnatal mesenchymal stem cells. Stem Cells 2016;34:1576-1587.
Laminin - pharmacology Mesenchymal Stromal Cells - drug effects Neovascularization, Physiologic - drug effects Gene Silencing - drug effects Endothelial Cells - metabolism Humans Dental Pulp - cytology Mesenchymal Stromal Cells - metabolism Glycogen Synthase Kinase 3 beta - antagonists & inhibitors Mice, SCID Glycogen Synthase Kinase 3 beta - metabolism beta Catenin - metabolism Gene Knockdown Techniques Mesenchymal Stromal Cells - cytology Animals Wnt Signaling Pathway - drug effects Proteoglycans - pharmacology Cell Differentiation - drug effects Endothelial Cells - cytology HEK293 Cells Collagen - pharmacology Vascular Endothelial Growth Factor A - pharmacology Drug Combinations Endothelial Cells - drug effects

Details

Logo image